Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Atrasentan in Pediatric Patients With Primary IgAN
- Status
- RECRUITING
- Phase
- PHASE3
Clinical Trials Related to Immunoglobulin A Nephropathy
Related studies linked through entity extraction aliases.
Study of Ravulizumab in Pediatric Participants With Primary IgAN
- Status
- RECRUITING
- Phase
- PHASE3
Study to Evaluate the Impact of Iptacopan on Top of SOC on Biopsy Changes in Kidneys of Adult Patients With IgAN
- Status
- RECRUITING
- Phase
- PHASE2
Study of Ravulizumab in Immunoglobulin A Nephropathy (IgAN)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Randomized, Double-blind, Placebo-controlled, Crossover Study of Atrasentan in Subjects With IgA Nephropathy
- Status
- COMPLETED
- Phase
- PHASE2
Trial of Sibeprenlimab in the Treatment of A Nephropathy (IgAN)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study of the Safety and Activity of Sparsentan for the Treatment of Patients With Immunoglobulin A Nephropathy
- Status
- RECRUITING
- Phase
- PHASE2
Atrasentan in Patients With Proteinuric Glomerular Diseases
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Atrasentan in Patients With IgA Nephropathy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3